These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30348181)

  • 1. Pharmacological neuroenhancement and the ability to recover from stress - a representative cross-sectional survey among the German population.
    Bagusat C; Kunzler A; Schlecht J; Franke AG; Chmitorz A; Lieb K
    Subst Abuse Treat Prev Policy; 2018 Oct; 13(1):37. PubMed ID: 30348181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Neuroenhancement, Perceived Stress, and Resilience in Spine Surgeons-A Cross-Sectional Survey.
    Chmitorz A; Ottenhausen M; Kalasauskas D; Irene I; Lieb K; Ringel F
    World Neurosurg; 2022 Feb; 158():e265-e276. PubMed ID: 34737099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To dope or not to dope: neuroenhancement with prescription drugs and drugs of abuse among Swiss university students.
    Maier LJ; Liechti ME; Herzig F; Schaub MP
    PLoS One; 2013; 8(11):e77967. PubMed ID: 24236008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of and motives for pharmacological neuroenhancement in Switzerland--results from a national Internet panel.
    Maier LJ; Haug S; Schaub MP
    Addiction; 2016 Feb; 111(2):280-95. PubMed ID: 26189457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relevance of pharmacological neuroenhancement for stress and resilience-A multistudy report.
    Darwig J; Gaum PM; Pauli R; Nassri L; Lang J
    Front Public Health; 2022; 10():971308. PubMed ID: 36438304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of stress, self-efficacy, and self-medication for pharmacological neuroenhancement among employees and students.
    Maier LJ; Haug S; Schaub MP
    Drug Alcohol Depend; 2015 Nov; 156():221-227. PubMed ID: 26455555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological cognitive enhancement among non-ADHD individuals-A cross-sectional study in 15 countries.
    Maier LJ; Ferris JA; Winstock AR
    Int J Drug Policy; 2018 Aug; 58():104-112. PubMed ID: 29902691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological Neuroenhancement: Current Aspects of Categorization, Epidemiology, Pharmacology, Drug Development, Ethics, and Future Perspectives.
    Daubner J; Arshaad MI; Henseler C; Hescheler J; Ehninger D; Broich K; Rawashdeh O; Papazoglou A; Weiergräber M
    Neural Plast; 2021; 2021():8823383. PubMed ID: 33519929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resilience and psychiatric symptoms as mediators between perceived stress and non-medical use of prescription drugs among college students.
    Tam CC; Benotsch EG; Weinstein TL
    Am J Drug Alcohol Abuse; 2020; 46(1):120-130. PubMed ID: 31442086
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-medical use of prescription drugs and its association with socio-demographic characteristics, dietary pattern, and perceived academic load and stress in college students in Puerto Rico.
    Betancourt J; Ríos JL; Pagán I; Fabián C; González AM; Cruz SY; González MJ; Rivera WT; Palacios C
    P R Health Sci J; 2013 Jun; 32(2):89-94. PubMed ID: 23781625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of illicit and prescription drugs for cognitive or mood enhancement among surgeons.
    Franke AG; Bagusat C; Dietz P; Hoffmann I; Simon P; Ulrich R; Lieb K
    BMC Med; 2013 Apr; 11():102. PubMed ID: 23570256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Neuroenhancement in the Field of Economics-Poll Results from an Online Survey.
    Dietz P; Soyka M; Franke AG
    Front Psychol; 2016; 7():520. PubMed ID: 27148128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective stressors in school and their relation to neuroenhancement: a behavioral perspective on students' everyday life "doping".
    Wolff W; Brand R
    Subst Abuse Treat Prev Policy; 2013 Jun; 8():23. PubMed ID: 23777577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroenhancement among German university students: motives, expectations, and relationship with psychoactive lifestyle drugs.
    Eickenhorst P; Vitzthum K; Klapp BF; Groneberg D; Mache S
    J Psychoactive Drugs; 2012; 44(5):418-27. PubMed ID: 23457893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating factors of self-care orientation and self-medication use in a Greek rural area.
    Papakosta M; Zavras D; Niakas D
    Rural Remote Health; 2014; 14():2349. PubMed ID: 24712873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential risk groups and psychological, psychosocial, and health behavioral predictors of pharmacological neuroenhancement among university students in Germany.
    Heller S; Tibubos AN; Hoff TA; Werner AM; Reichel JL; Mülder LM; Schäfer M; Pfirrmann D; Stark B; Rigotti T; Simon P; Beutel ME; Letzel S; Dietz P
    Sci Rep; 2022 Jan; 12(1):937. PubMed ID: 35042938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric Comorbidity and Stress in Medical Students Using Neuroenhancers.
    Jebrini T; Manz K; Koller G; Krause D; Soyka M; Franke AG
    Front Psychiatry; 2021; 12():771126. PubMed ID: 34975573
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-Medical Prescription Stimulant Use in Graduate Students: Relationship With Academic Self-Efficacy and Psychological Variables.
    Verdi G; Weyandt LL; Zavras BM
    J Atten Disord; 2016 Sep; 20(9):741-53. PubMed ID: 24756173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COgnitive enhancement and consumption of psychoactive Substances among Youth Students (COSYS): a cross-sectional study in France.
    Batisse A; Leger S; Vicaut E; Gerbaud L; Djezzar S
    Public Health; 2021 May; 194():75-78. PubMed ID: 33865150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors.
    Lucas P; Walsh Z; Crosby K; Callaway R; Belle-Isle L; Kay R; Capler R; Holtzman S
    Drug Alcohol Rev; 2016 May; 35(3):326-33. PubMed ID: 26364922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.